Table 1.
Demographic characteristics and clinical data
| n | % | |
|---|---|---|
| C. neoformans infection | 25 | |
| Sex | ||
| Male | 12 | 48 |
| Data not available | 9 | 36 |
| Mean age (if available to laboratory) | 45 | |
| Underlying disease | ||
| HIV infection | 19 | 76 |
| Immunosuppressive therapy | 3 | 12 |
| Congenital immunodeficiency | 1 | 4 |
| Risk factors not identified | 1 | 4 |
| Information not available | 1 | 4 |
| Focus of infection | ||
| Meningitis | 14 | 56 |
| Blood stream infection | 2 | 8 |
| Data not available | 9 | 36 |
| Evidence for proven IFI | ||
| Culture positivity | 13 | 52 |
| CSF antigen positivity | 12 | 48 |
| Non-Cryptococcus basidiomycete yeast infection | 2 | 5 |
| Male sex | 2 | 100 |
| Mean age (in years) | 41 | |
| Characteristics of infection | ||
| Meningitis by N. albida | 1 | 50 |
| Wound infection by F. magnum | 1 | 50 |
| Evidence for proven IFI | ||
| Culture positivity | 2 | 100 |
| No evidence of cryptococcosis | 20 | |
| Male sex | 11 | 55 |
| Mean age (in years) | 58 | |
| Indication for lumbar puncture | ||
| Psychiatric assessment | 18 | 90 |
| Neurological assessment | 2 | 10 |
Non-Cryptococcus basidiomycete yeast infections included in this study were caused by Naganishia albida (formerly classified as C. albidus) and Filobasidium magnum (formerly classified as C. magnus)